Dow sells Angus Chemical to Golden Gate Capital for $1.215 bn
The divestiture aligns to Dow's efforts to achieve its identified target of $ 4.5 billion to $ 6 billion in proceeds from shedding non-strategic assets and businesses by year-end 2015
BS B2B Bureau B2B Connect | Houston, USA

Dow had previously announced its intent to divest this business on October 2, 2014. The divestiture aligns to Dow’s efforts to achieve its identified target of $ 4.5 billion to $ 6 billion in proceeds from shedding non-strategic assets and businesses by year-end 2015. To date, Dow has achieved $2.5 billion in proceeds designed to remunerate shareholders, reduce debt, and fund growth.
Angus is the world's only chemical company dedicated to the manufacture and distribution of nitroalkanes and their derivatives, which are extremely versatile additives and intermediates that help customers to enhance their products’ performance. Industries successfully using Angus’ products include paints and coatings, life sciences and biopharma, metalworking, personal care, pharmaceuticals, water treatment, oil & gas and many others.
Also Read
The divestiture of Angus Chemical includes the business headquarters and R&D facility in Buffalo Grove, IL; manufacturing facilities located in Sterlington, LA, and Ibbenbueren, Germany; a packaging facility in Niagara Falls, NY; as well as the associated business, inventory, customer contracts, process technology, business know-how and certain intellectual property.
Approximately 290 employee positions globally are expected to transition employment status as Angus moves to being owned by Golden Gate Capital as part of the transaction. Under terms of the purchase agreement, Angus will continue to honour customer, licensing and supplier contracts and related agreements.
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Nov 13 2014 | 9:01 AM IST